Phase II trial of cisplatin, interferon α-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer

Clinical Cancer Research

Volumn 7, Issue 11, 2001, Pages 3375-3380

  Patt, Y Z ^a   Hassan, M M ^a   Lozano, R D ^a   Waugh, K A ^a   Hoque, A M ^a   Frome, A I ^a   Lahoti, S ^a   Ellis, L ^a   Vauthey, J N ^a   Curley, S A ^a   Schnirer, I I ^a   Raijman, I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN; DOXORUBICIN; FLUOROURACIL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; GALLBLADDER CARCINOMA; HUMAN; MALE; NAUSEA AND VOMITING; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIARY TRACT NEOPLASMS; CISPLATIN; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FATIGUE; FEMALE; FLUOROURACIL; HEMATOLOGIC DISEASES; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; NAUSEA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VOMITING;

EID: 0035186224     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cancer statistics
2. Cancer statistics
3. Rising incidence of hepatocellular carcinoma in the United States
4. Risk factors for the rising rates of primary liver cancer in the United States
5. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C-virus-related cirrhosis
6. Phase II trial of intravenous flourouracil and subcutaneous interferon α-2b for biliary tract cancer
7. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatitis
8. The role of chemotherapy in the treatment of bile duct cancer
9. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma
10. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin
11. Eastern Cooperative Oncology Group experiences with chemotherapy for inoperable gallbladder and bile duct cancer
12. Adriamycin, BCNU, FTORAFUR chemotherapy of pancreatic and biliary tract cancer
13. 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract
14. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clinical trial. Clinical trial, phase II
15. Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant α2B, doxorubicin, and 5-fluorouracil: A communication
16. Reporting results of cancer treatment
17. Optimal two-stage designs for phase II clinical trials
18. Non-parametric estimation from incomplete observations
19. A generalized Wilcoxon test for comparing arbitrarily single censored samples